Embla Medical – Recording of Q3 2024 result presentation
Today, Embla Medical's CEO Sveinn Solvason presented and answered questions about the Q3 2024 results, the expectations for the rest of the year, and details about the increased reimbursement on the US market. Changes that creates a large market potential trough access to more advanced solutions for patients.
https://www.inderes.dk/videos/embla-medical-presentation-of-interim-report-q3-2024
Embla Medical is a leading global provider of innovative mobility solutions in the medical technology space. Embla Medical improves people’s mobility through the delivery of Prosthetics, Bracing & Supports, and accompanying Patient Care. Headquartered in Iceland, the company employs over 4,000. Embla Medical has extensive operations in the Americas, Europe, and Asia, as well as distributors in other markets.
Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 15:38, 23 October 2024.
Embla Medical
Embla Medical er en førende global leverandør af innovative mobilitetsløsninger i medtech-sektoren. Embla Medical forbedrer folks mobilitet gennem levering af proteser, afstivning og støtte og ledsagende patientpleje. Virksomheden har hovedkvarter i Island og beskæftiger over 4.000 mennesker i 36 lande verden over. Embla Medical har omfattende aktiviteter i Nord- og Sydamerika, Europa og Asien samt distributører på andre markeder.
Read more on company page